Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
Clinical trial NCT01423110 · COMPLETED
Trial details
- NCT number
- NCT01423110
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.